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Psychiatric co-morbidity in adolescents is common, with the majority of those who have depression 
also having at least one anxiety disorder, and many meeting the diagnostic criteria for more than 
one anxiety disorder1. In our recent paper published in this journal, we reported that approximately 
one in three adolescents with Chronic Fatigue Syndrome (CFS/ME) has either an anxiety disorder, or 
major depressive disorder, or both2.  
In clinical practice, screening questionnaires which ask about depression and anxiety symptoms, 
such as the Revised Children’s Anxiety and Depression Scale, RCADS3, and the Hospital Anxiety and 
Depression Scale, HADS4, are often used as part of the assessment process. However, in our paper, 
we reported our findings of variable discriminative validity of these questionnaires for detecting 
anxiety and depression separately2. Whilst we found sufficiently accurate threshold scores for 
classifying those with anxiety disorders on both the 47-item and 25 item parent and child versions of 
the RCADS, we could not identify a sufficiently accurate threshold score for classifying those with 
depression. We also could not identify sufficiently accurate threshold scores on the HADS for either 
anxiety or depression.    
Clinicians treating children with health disorders need a simple screening mechanism to identify 
those with co-morbid mental health problems that will require further assessment. Using one 
threshold score, is therefore arguably more useful than calculating two separate scores (for 
depression and anxiety). Given the high co-morbidity between depression and anxiety in this 
population, we sought to identify the threshold score for mental health problems on two commonly 
used screening questionnaires, the RCADS-total and the HADS-total. 
 
Method 
We reported our methods extensively in our paper, and therefore will summarise them here (for full 
details see2). We conducted a cross-sectional study in a clinical cohort of adolescents, aged 12 to 18, 
with a confirmed diagnosis of CFS/ME. Eligible adolescents were recruited at or following their initial 
assessment at a specialist paediatric CFS/ME service.  
They completed the following questionnaires:  
Revised Children’s Anxiety and Depression Scale (RCADS)3 – The full form of the RCADS has 47 items, 
10 of which pertain to depression and 37 to anxiety. Each item is rated on a 4-point scale. 
Additionally, there is a brief 25 item version (10 depression and 15 anxiety items) version. We have 
previously tested the depression and anxiety items of the full and brief versions of the RCADS for 
identifying depression and anxiety respectively2. We have not previously tested the total score on 
the self-report RCADS for identifying co-morbid anxiety and/or depression.  
Hospital Anxiety and Depression Scale (HADS)4 - The 14 item self-report HADS has  7 anxiety items 
and 7 depression items. Each item is rated on a 4-point scale. In adults, the HADS may be better as a 
measure of general distress rather than one which discriminates between anxiety and depression 5. 
Adolescents and parent informants were interviewed using the Kiddie Schedule for Affective 
Disorders and Schizophrenia 6 to identify anxiety disorders and/or major depressive disorder, 
henceforth referred to as ‘depression’.   
We used Receiver Operating Characteristic (ROC) curve analysis to examine the diagnostic accuracy 
of the questionnaires for detecting mental health problems (anxiety and/or depression). Specifically, 
the RCADS-total (all 47-item version and those 25-items which make up the brief version) and HADS-
 
 
total. We considered an area under the curve (AUC) of >.70 to indicate at least moderate accuracy. 
In clinical settings, sensitivity is more desirable than specificity; hence, we sought optimal thresholds 
with a sensitivity of ≥ 0.8 and a specificity of ≥ 0.7.  
 
Results & Discussion 
A total of 164 participants, mean age 15, mostly female (70%) completed the HADS and a subsample 
of 89 (54%) completed the RCADS. The subsample did not differ significantly on fatigue, physical 
functioning, HADS-total or age (data not shown).    
We constructed ROC curves (see figs 1.a and b). All the RCADS versions tested were at least 
moderately accurate for classifying co-morbid mental health problems (anxiety and/or depression) - 
see table 1. The HADS-total was also at least moderately accurate. For classifying co-morbid mental 
health problems (anxiety and/or depression), we were able to identify threshold scores reaching the 
0.8/0.7 requirement on the 47 item RCADS and the 25 item RCADS. We were not able to identify a 
threshold score reaching this requirement on the HADS, although ≥ 18 was closest at 0.76/0.69.  
 
For identifying co-morbid mental health problems (anxiety and/or depression), we found that both 
the full 47 item version and the brief 25 item version of the RCADS were sufficiently accurate and 
could identify threshold scores deemed to be suitably sensitive and specific to be useful for 
screening in a clinical setting. Given that the assessment burden of the full RCADS is almost double 
that of the brief version our findings suggest that the RCADS-25 is robust to be used with this client 
group. A total cut-off score of >27 will correctly identify 87% of those who have co-morbid mental 
health problems and 72% of those who do not have a co-morbid mental health problem as 
diagnosed using the KSADS diagnostic interview. We could not however, identify sufficiently 
sensitive and specific threshold scores on the HADS, with a score of ≥ 18 correctly identifying 76% of 
those who have co-morbid mental health problems and 69% of those who do not.     
 
Participants were recruited from specialist services, so findings may not generalise to other settings, 
nor to those who were too severely affected to participate. The diagnostic interview was also 
assumed to be completely accurate, and whilst we made every attempt to ensure that it was 
robustly conducted, diagnostic judgements may mean that errors were made. Nonetheless, our 
findings suggest that a total cut-off score of >27 on the 25 item RCADS offers a simple way of 




Table 1. Receiver Operating Characteristics for questionnaires 

































































AUC – area under the curve; CI – confidence interval; HADS – Hospital Anxiety and Depression Scale 
RCADS – Revised Children’s Anxiety and Depression Scale;  
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